Osiris Therapeutics

Osiris Therapeutics

Osiris Therapeutics is a biotechnology company making stem cell products to treat medical conditions.

Osiris Therapeutics is a regenerative medicine company involved research, development and manufacturing of product in orthopedics, sports medicine and wound care. Key products include the Grafix product line which includes Stravix, BIO4 and Cartiform.

Timeline

April 17, 2019

Smith & Nephew Completes Acquisition of Osiris Therapeutics,

Smith & Nephew plc today announces completion of the acquisition of Osiris Therapeutics, Inc. for $19.00 per share in cash, representing a total equity value of approximately $660 million.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Subscribe to read | Financial Times

Arash Massoudi

Web

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Brad Perriello
March 27, 2019
MassDevice
The Medical Device Business Journal -- Medical Device News & Articles | MassDevice
Brad Perriello
March 12, 2019
MassDevice
The Medical Device Business Journal -- Medical Device News & Articles | MassDevice
Brad Perriello
December 14, 2018
MassDevice
The Medical Device Business Journal -- Medical Device News & Articles | MassDevice

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.